FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4291291331> ?p ?o ?g. }

• W4291291331 endingPage "S152" @default.
• W4291291331 startingPage "S152" @default.
• W4291291331 abstract "We present a case of a mixed martial art athlete found positive to methasterone metabolites, ligandrol and cardarine metabolites after an anti-doping testing. The athlete denied any drugs consumption but provided the list of 23 nutritional supplements under use during competition. The aim of the present study was to analyse the provided material to support evidence of unintentional doping. Cumulatively, products were commercialised either as pre-workout, intra-workout and post-workout adjuvants containing amino acids, creatine and proteins or as cofactors and vitamins to recover after training. Four products were taken to aid sleeping and one was a “testosterone boost”. All samples were submitted to analysis by liquid-chromatography/high resolution mass spectrometry (LC-QTOF). One hundred milligrams of material (powders, pills, oily pills, capsules) were sampled and dissolved with 10 mL of methanol, vortexed for 30 and sonicated for 30 min. The extracts were centrifuged at 3000 rpm for 5 min at 25 °C. The supernatants were appropriately diluted with deionised water then 5 μL injected into the LC-MS. Separations were carried out in a Zorbax C18 (2.1 × 100, 1.8 μm) column in 5 mM ammonium formate (mobile phase A) and methanol (mobile phase B), both added of 0.1% formic acid, flow at 0.2 mL/min. Acquisitions were carried out in positive polarity MS scan mode and MS/MS for fragment confirmation. Sensitivity expressed as method detection limit (MDL), linearity, carry-over, dilution integrity, accuracy and precision were tested under the described conditions for cardarine, methasterone and ligandrol. The analysis of the samples showed 2 out the 23 nutritional products containing the illicit substances. Methasterone, cardarine and ligandrol were alongside present in one sample (S1) at the respective concentrations of 5 μg/mg, 11.8 μg/mg and 1.4 μg/mg. Cardarine and ligandrol were confirmed in a second sample (S2) at the concentration of 0.6 and 0.2 μg/mg, respectively. Two products resulted contaminated with methasterone, cardarine and ligandrol. The calculated concentration for all substances > 1 μg/mg in S1 product may presume an intentional manipulation with pharmacologically active ingredients that better fitted the promise of enhanced recovery and improved endurance. In S2 ligandrol and cardarine amounts are compatible with a cross-contamination scenario. Conclusion: methasterone, ligandrol and cardarine were complessively detected in 2 samples. Since no labelling declared the retrieved substances, this might have represented a case of unintentional doping." @default.
• W4291291331 created "2022-08-14" @default.
• W4291291331 creator A5011584200 @default.
• W4291291331 creator A5018493371 @default.
• W4291291331 creator A5022016136 @default.
• W4291291331 creator A5032637306 @default.
• W4291291331 creator A5049701385 @default.
• W4291291331 creator A5074277610 @default.
• W4291291331 date "2022-09-01" @default.
• W4291291331 modified "2023-10-18" @default.
• W4291291331 title "Detection of multiple prohibited ingredients in nutritional supplements in a case of doping" @default.
• W4291291331 doi "https://doi.org/10.1016/j.toxac.2022.06.257" @default.
• W4291291331 hasPublicationYear "2022" @default.
• W4291291331 type Work @default.
• W4291291331 citedByCount "0" @default.
• W4291291331 crossrefType "journal-article" @default.
• W4291291331 hasAuthorship W4291291331A5011584200 @default.
• W4291291331 hasAuthorship W4291291331A5018493371 @default.
• W4291291331 hasAuthorship W4291291331A5022016136 @default.
• W4291291331 hasAuthorship W4291291331A5032637306 @default.
• W4291291331 hasAuthorship W4291291331A5049701385 @default.
• W4291291331 hasAuthorship W4291291331A5074277610 @default.
• W4291291331 hasBestOaLocation W42912913311 @default.
• W4291291331 hasConcept C161790260 @default.
• W4291291331 hasConcept C178790620 @default.
• W4291291331 hasConcept C185592680 @default.
• W4291291331 hasConcept C2775986502 @default.
• W4291291331 hasConcept C2777379063 @default.
• W4291291331 hasConcept C2779607525 @default.
• W4291291331 hasConcept C2780178953 @default.
• W4291291331 hasConcept C43617362 @default.
• W4291291331 hasConcept C55493867 @default.
• W4291291331 hasConceptScore W4291291331C161790260 @default.
• W4291291331 hasConceptScore W4291291331C178790620 @default.
• W4291291331 hasConceptScore W4291291331C185592680 @default.
• W4291291331 hasConceptScore W4291291331C2775986502 @default.
• W4291291331 hasConceptScore W4291291331C2777379063 @default.
• W4291291331 hasConceptScore W4291291331C2779607525 @default.
• W4291291331 hasConceptScore W4291291331C2780178953 @default.
• W4291291331 hasConceptScore W4291291331C43617362 @default.
• W4291291331 hasConceptScore W4291291331C55493867 @default.
• W4291291331 hasIssue "3" @default.
• W4291291331 hasLocation W42912913311 @default.
• W4291291331 hasOpenAccess W4291291331 @default.
• W4291291331 hasPrimaryLocation W42912913311 @default.
• W4291291331 hasRelatedWork W1554978821 @default.
• W4291291331 hasRelatedWork W1975088719 @default.
• W4291291331 hasRelatedWork W1990710770 @default.
• W4291291331 hasRelatedWork W2031923059 @default.
• W4291291331 hasRelatedWork W2062741401 @default.
• W4291291331 hasRelatedWork W2070322608 @default.
• W4291291331 hasRelatedWork W2072334494 @default.
• W4291291331 hasRelatedWork W2320458394 @default.
• W4291291331 hasRelatedWork W2325264213 @default.
• W4291291331 hasRelatedWork W2602096934 @default.
• W4291291331 hasVolume "34" @default.
• W4291291331 isParatext "false" @default.
• W4291291331 isRetracted "false" @default.
• W4291291331 workType "article" @default.